Sexton Biotechnologies Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $39.9M

Sexton Biotechnologies General Information

Description

Developer of bio-production tools for cell and gene therapy designed to allow flexible integration to accelerate and automate the cell and gene manufacturing process. The company's products include purpose-built CGT tools and media, vial adapters, storage racks, radio-frequency tube sealing systems and more, enabling biotech firms to increase the probability of positive clinical outcomes and reduce time-to-market, failure points and labor costs.

Contact Information

Website
www.sextonbio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1102 Indiana Avenue
  • Indianapolis, IN 46202
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Acquirer
Biolife Solutions
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • 1102 Indiana Avenue
  • Indianapolis, IN 46202
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sexton Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Sep-2021 $39.9M Completed Generating Revenue
1. Early Stage VC (Series A) 24-Sep-2019 Completed Generating Revenue
To view Sexton Biotechnologies’s complete valuation and funding history, request access »

Sexton Biotechnologies Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Sexton Biotechnologies’s complete cap table history, request access »

Sexton Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-production tools for cell and gene therapy designed to allow flexible integration to accelerate and aut
Discovery Tools (Healthcare)
Indianapolis, IN
20 As of 2021

Bergisch Gladbach, Germany
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sexton Biotechnologies Competitors (33)

One of Sexton Biotechnologies’s 33 competitors is Miltenyi Biotec, a Private Debt Financed company based in Bergisch Gladbach, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany
bit.bio Venture Capital-Backed Cambridge, United Kingdom
ScienCell Research Laboratories Corporation Carlsbad, CA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Lifeline Cell Technology Corporate Backed or Acquired Frederick, MD
You’re viewing 5 of 33 competitors. Get the full list »

Sexton Biotechnologies Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Sexton Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023214502-A1 Cryogenic storage container Active 07-Feb-2022
AU-2023214502-B2 Cryogenic storage container Active 07-Feb-2022
EP-4476491-A2 Cryogenic storage container Pending 07-Feb-2022
EP-4476491-A4 Cryogenic storage container Pending 07-Feb-2022
US-20230247983-A1 Cryogenic storage container Pending 07-Feb-2022 A01N1/146
To view Sexton Biotechnologies’s complete patent history, request access »

Sexton Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sexton Biotechnologies Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioCrossroads Venture Capital Minority
Casdin Capital Venture Capital Minority
Cook Regentec Accelerator/Incubator Minority
To view Sexton Biotechnologies’s complete investors history, request access »

Ready to get started?

Request a free trial

Sexton Biotechnologies FAQs

  • When was Sexton Biotechnologies founded?

    Sexton Biotechnologies was founded in 2019.

  • Where is Sexton Biotechnologies headquartered?

    Sexton Biotechnologies is headquartered in Indianapolis, IN.

  • What is the size of Sexton Biotechnologies?

    Sexton Biotechnologies has 20 total employees.

  • What industry is Sexton Biotechnologies in?

    Sexton Biotechnologies’s primary industry is Discovery Tools (Healthcare).

  • Is Sexton Biotechnologies a private or public company?

    Sexton Biotechnologies is a Private company.

  • What is the current valuation of Sexton Biotechnologies?

    The current valuation of Sexton Biotechnologies is .

  • What is Sexton Biotechnologies’s current revenue?

    The current revenue for Sexton Biotechnologies is .

  • How much funding has Sexton Biotechnologies raised over time?

    Sexton Biotechnologies has raised $5M.

  • Who are Sexton Biotechnologies’s investors?

    BioCrossroads, Casdin Capital, and Cook Regentec have invested in Sexton Biotechnologies.

  • Who are Sexton Biotechnologies’s competitors?

    Miltenyi Biotec, bit.bio, ScienCell Research Laboratories, Abcam, and Lifeline Cell Technology are some of the 33 competitors of Sexton Biotechnologies.

  • When was Sexton Biotechnologies acquired?

    Sexton Biotechnologies was acquired on 01-Sep-2021.

  • Who acquired Sexton Biotechnologies?

    Sexton Biotechnologies was acquired by Biolife Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process